{"nct_id":"NCT04349306","title":"Evaluate the Efficacy and Safety of Rasburicase (Fasturtec®) in the Prevention and Treatment of Hyperuricemia in Pediatric Patients With Non-Hodgkin's Lymphoma and Acute Leukemia","status":"COMPLETED","status_verified_date":"2022-04","start_date":"2020-05-14","start_date_type":"ACTUAL","primary_completion_date":"2021-03-12","primary_completion_date_type":"ACTUAL","completion_date":"2021-03-12","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["SNY"]}